Global Montelukast Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Montelukast Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Montelukast Drug industry chain, the market status of Hospital (Tablets, Oral Granules), Drug Store (Tablets, Oral Granules), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Montelukast Drug.
Regionally, the report analyzes the Montelukast Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Montelukast Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Montelukast Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Montelukast Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Tablets, Oral Granules).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Montelukast Drug market.
Regional Analysis: The report involves examining the Montelukast Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Montelukast Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Montelukast Drug:
Company Analysis: Report covers individual Montelukast Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Montelukast Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Drug Store).
Technology Analysis: Report covers specific technologies relevant to Montelukast Drug. It assesses the current state, advancements, and potential future developments in Montelukast Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Montelukast Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Montelukast Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Montelukast Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Montelukast Drug, with price, sales, revenue and global market share of Montelukast Drug from 2019 to 2024.
Chapter 3, the Montelukast Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Montelukast Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Montelukast Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Montelukast Drug.
Chapter 14 and 15, to describe Montelukast Drug sales channel, distributors, customers, research findings and conclusion.
Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Montelukast Drug industry chain, the market status of Hospital (Tablets, Oral Granules), Drug Store (Tablets, Oral Granules), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Montelukast Drug.
Regionally, the report analyzes the Montelukast Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Montelukast Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Montelukast Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Montelukast Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Tablets, Oral Granules).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Montelukast Drug market.
Regional Analysis: The report involves examining the Montelukast Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Montelukast Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Montelukast Drug:
Company Analysis: Report covers individual Montelukast Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Montelukast Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Drug Store).
Technology Analysis: Report covers specific technologies relevant to Montelukast Drug. It assesses the current state, advancements, and potential future developments in Montelukast Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Montelukast Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Montelukast Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Tablets
- Oral Granules
- Hospital
- Drug Store
- Others
- Merck & Co.
- Teva
- Mylan
- Glenmark Pharmaceuticals
- Hikma Group
- Sandoz
- Torrent Pharmaceuticals
- Lannett Company
- Apotex
- Dr. Reddys Laboratories
- Aurobindo Pharma
- Accord Healthcare
- Hetero
- Unimark
- Ajanta Pharma
- MACLEODS
- Jubilant Pharma
- Unichem Laboratories
- Amneal Pharmaceuticals
- Shanghai Anbison Lab
- Perrigo
- Cipla
- CSPC Ouyi Pharmaceutical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Montelukast Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Montelukast Drug, with price, sales, revenue and global market share of Montelukast Drug from 2019 to 2024.
Chapter 3, the Montelukast Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Montelukast Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Montelukast Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Montelukast Drug.
Chapter 14 and 15, to describe Montelukast Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Montelukast Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Montelukast Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Tablets
1.3.3 Oral Granules
1.4 Market Analysis by Application
1.4.1 Overview: Global Montelukast Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Drug Store
1.4.4 Others
1.5 Global Montelukast Drug Market Size & Forecast
1.5.1 Global Montelukast Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Montelukast Drug Sales Quantity (2019-2030)
1.5.3 Global Montelukast Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Montelukast Drug Product and Services
2.1.4 Merck & Co. Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck & Co. Recent Developments/Updates
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Montelukast Drug Product and Services
2.2.4 Teva Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Teva Recent Developments/Updates
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Montelukast Drug Product and Services
2.3.4 Mylan Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Mylan Recent Developments/Updates
2.4 Glenmark Pharmaceuticals
2.4.1 Glenmark Pharmaceuticals Details
2.4.2 Glenmark Pharmaceuticals Major Business
2.4.3 Glenmark Pharmaceuticals Montelukast Drug Product and Services
2.4.4 Glenmark Pharmaceuticals Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Glenmark Pharmaceuticals Recent Developments/Updates
2.5 Hikma Group
2.5.1 Hikma Group Details
2.5.2 Hikma Group Major Business
2.5.3 Hikma Group Montelukast Drug Product and Services
2.5.4 Hikma Group Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Hikma Group Recent Developments/Updates
2.6 Sandoz
2.6.1 Sandoz Details
2.6.2 Sandoz Major Business
2.6.3 Sandoz Montelukast Drug Product and Services
2.6.4 Sandoz Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sandoz Recent Developments/Updates
2.7 Torrent Pharmaceuticals
2.7.1 Torrent Pharmaceuticals Details
2.7.2 Torrent Pharmaceuticals Major Business
2.7.3 Torrent Pharmaceuticals Montelukast Drug Product and Services
2.7.4 Torrent Pharmaceuticals Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Torrent Pharmaceuticals Recent Developments/Updates
2.8 Lannett Company
2.8.1 Lannett Company Details
2.8.2 Lannett Company Major Business
2.8.3 Lannett Company Montelukast Drug Product and Services
2.8.4 Lannett Company Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Lannett Company Recent Developments/Updates
2.9 Apotex
2.9.1 Apotex Details
2.9.2 Apotex Major Business
2.9.3 Apotex Montelukast Drug Product and Services
2.9.4 Apotex Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Apotex Recent Developments/Updates
2.10 Dr. Reddys Laboratories
2.10.1 Dr. Reddys Laboratories Details
2.10.2 Dr. Reddys Laboratories Major Business
2.10.3 Dr. Reddys Laboratories Montelukast Drug Product and Services
2.10.4 Dr. Reddys Laboratories Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Dr. Reddys Laboratories Recent Developments/Updates
2.11 Aurobindo Pharma
2.11.1 Aurobindo Pharma Details
2.11.2 Aurobindo Pharma Major Business
2.11.3 Aurobindo Pharma Montelukast Drug Product and Services
2.11.4 Aurobindo Pharma Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Aurobindo Pharma Recent Developments/Updates
2.12 Accord Healthcare
2.12.1 Accord Healthcare Details
2.12.2 Accord Healthcare Major Business
2.12.3 Accord Healthcare Montelukast Drug Product and Services
2.12.4 Accord Healthcare Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Accord Healthcare Recent Developments/Updates
2.13 Hetero
2.13.1 Hetero Details
2.13.2 Hetero Major Business
2.13.3 Hetero Montelukast Drug Product and Services
2.13.4 Hetero Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Hetero Recent Developments/Updates
2.14 Unimark
2.14.1 Unimark Details
2.14.2 Unimark Major Business
2.14.3 Unimark Montelukast Drug Product and Services
2.14.4 Unimark Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Unimark Recent Developments/Updates
2.15 Ajanta Pharma
2.15.1 Ajanta Pharma Details
2.15.2 Ajanta Pharma Major Business
2.15.3 Ajanta Pharma Montelukast Drug Product and Services
2.15.4 Ajanta Pharma Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Ajanta Pharma Recent Developments/Updates
2.16 MACLEODS
2.16.1 MACLEODS Details
2.16.2 MACLEODS Major Business
2.16.3 MACLEODS Montelukast Drug Product and Services
2.16.4 MACLEODS Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 MACLEODS Recent Developments/Updates
2.17 Jubilant Pharma
2.17.1 Jubilant Pharma Details
2.17.2 Jubilant Pharma Major Business
2.17.3 Jubilant Pharma Montelukast Drug Product and Services
2.17.4 Jubilant Pharma Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Jubilant Pharma Recent Developments/Updates
2.18 Unichem Laboratories
2.18.1 Unichem Laboratories Details
2.18.2 Unichem Laboratories Major Business
2.18.3 Unichem Laboratories Montelukast Drug Product and Services
2.18.4 Unichem Laboratories Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Unichem Laboratories Recent Developments/Updates
2.19 Amneal Pharmaceuticals
2.19.1 Amneal Pharmaceuticals Details
2.19.2 Amneal Pharmaceuticals Major Business
2.19.3 Amneal Pharmaceuticals Montelukast Drug Product and Services
2.19.4 Amneal Pharmaceuticals Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Amneal Pharmaceuticals Recent Developments/Updates
2.20 Shanghai Anbison Lab
2.20.1 Shanghai Anbison Lab Details
2.20.2 Shanghai Anbison Lab Major Business
2.20.3 Shanghai Anbison Lab Montelukast Drug Product and Services
2.20.4 Shanghai Anbison Lab Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Shanghai Anbison Lab Recent Developments/Updates
2.21 Perrigo
2.21.1 Perrigo Details
2.21.2 Perrigo Major Business
2.21.3 Perrigo Montelukast Drug Product and Services
2.21.4 Perrigo Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Perrigo Recent Developments/Updates
2.22 Cipla
2.22.1 Cipla Details
2.22.2 Cipla Major Business
2.22.3 Cipla Montelukast Drug Product and Services
2.22.4 Cipla Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Cipla Recent Developments/Updates
2.23 CSPC Ouyi Pharmaceutical
2.23.1 CSPC Ouyi Pharmaceutical Details
2.23.2 CSPC Ouyi Pharmaceutical Major Business
2.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Product and Services
2.23.4 CSPC Ouyi Pharmaceutical Montelukast Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MONTELUKAST DRUG BY MANUFACTURER
3.1 Global Montelukast Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Montelukast Drug Revenue by Manufacturer (2019-2024)
3.3 Global Montelukast Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Montelukast Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Montelukast Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Montelukast Drug Manufacturer Market Share in 2023
3.5 Montelukast Drug Market: Overall Company Footprint Analysis
3.5.1 Montelukast Drug Market: Region Footprint
3.5.2 Montelukast Drug Market: Company Product Type Footprint
3.5.3 Montelukast Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Montelukast Drug Market Size by Region
4.1.1 Global Montelukast Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Montelukast Drug Consumption Value by Region (2019-2030)
4.1.3 Global Montelukast Drug Average Price by Region (2019-2030)
4.2 North America Montelukast Drug Consumption Value (2019-2030)
4.3 Europe Montelukast Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Montelukast Drug Consumption Value (2019-2030)
4.5 South America Montelukast Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Montelukast Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Montelukast Drug Sales Quantity by Type (2019-2030)
5.2 Global Montelukast Drug Consumption Value by Type (2019-2030)
5.3 Global Montelukast Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Montelukast Drug Sales Quantity by Application (2019-2030)
6.2 Global Montelukast Drug Consumption Value by Application (2019-2030)
6.3 Global Montelukast Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Montelukast Drug Sales Quantity by Type (2019-2030)
7.2 North America Montelukast Drug Sales Quantity by Application (2019-2030)
7.3 North America Montelukast Drug Market Size by Country
7.3.1 North America Montelukast Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Montelukast Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Montelukast Drug Sales Quantity by Type (2019-2030)
8.2 Europe Montelukast Drug Sales Quantity by Application (2019-2030)
8.3 Europe Montelukast Drug Market Size by Country
8.3.1 Europe Montelukast Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Montelukast Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Montelukast Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Montelukast Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Montelukast Drug Market Size by Region
9.3.1 Asia-Pacific Montelukast Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Montelukast Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Montelukast Drug Sales Quantity by Type (2019-2030)
10.2 South America Montelukast Drug Sales Quantity by Application (2019-2030)
10.3 South America Montelukast Drug Market Size by Country
10.3.1 South America Montelukast Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Montelukast Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Montelukast Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Montelukast Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Montelukast Drug Market Size by Country
11.3.1 Middle East & Africa Montelukast Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Montelukast Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Montelukast Drug Market Drivers
12.2 Montelukast Drug Market Restraints
12.3 Montelukast Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Montelukast Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Montelukast Drug
13.3 Montelukast Drug Production Process
13.4 Montelukast Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Montelukast Drug Typical Distributors
14.3 Montelukast Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Montelukast Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Montelukast Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Montelukast Drug Product and Services
Table 6. Merck & Co. Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck & Co. Recent Developments/Updates
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Major Business
Table 10. Teva Montelukast Drug Product and Services
Table 11. Teva Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Teva Recent Developments/Updates
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Major Business
Table 15. Mylan Montelukast Drug Product and Services
Table 16. Mylan Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Mylan Recent Developments/Updates
Table 18. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Glenmark Pharmaceuticals Major Business
Table 20. Glenmark Pharmaceuticals Montelukast Drug Product and Services
Table 21. Glenmark Pharmaceuticals Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Glenmark Pharmaceuticals Recent Developments/Updates
Table 23. Hikma Group Basic Information, Manufacturing Base and Competitors
Table 24. Hikma Group Major Business
Table 25. Hikma Group Montelukast Drug Product and Services
Table 26. Hikma Group Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Hikma Group Recent Developments/Updates
Table 28. Sandoz Basic Information, Manufacturing Base and Competitors
Table 29. Sandoz Major Business
Table 30. Sandoz Montelukast Drug Product and Services
Table 31. Sandoz Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sandoz Recent Developments/Updates
Table 33. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Torrent Pharmaceuticals Major Business
Table 35. Torrent Pharmaceuticals Montelukast Drug Product and Services
Table 36. Torrent Pharmaceuticals Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Torrent Pharmaceuticals Recent Developments/Updates
Table 38. Lannett Company Basic Information, Manufacturing Base and Competitors
Table 39. Lannett Company Major Business
Table 40. Lannett Company Montelukast Drug Product and Services
Table 41. Lannett Company Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Lannett Company Recent Developments/Updates
Table 43. Apotex Basic Information, Manufacturing Base and Competitors
Table 44. Apotex Major Business
Table 45. Apotex Montelukast Drug Product and Services
Table 46. Apotex Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Apotex Recent Developments/Updates
Table 48. Dr. Reddys Laboratories Basic Information, Manufacturing Base and Competitors
Table 49. Dr. Reddys Laboratories Major Business
Table 50. Dr. Reddys Laboratories Montelukast Drug Product and Services
Table 51. Dr. Reddys Laboratories Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Dr. Reddys Laboratories Recent Developments/Updates
Table 53. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Aurobindo Pharma Major Business
Table 55. Aurobindo Pharma Montelukast Drug Product and Services
Table 56. Aurobindo Pharma Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Aurobindo Pharma Recent Developments/Updates
Table 58. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 59. Accord Healthcare Major Business
Table 60. Accord Healthcare Montelukast Drug Product and Services
Table 61. Accord Healthcare Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Accord Healthcare Recent Developments/Updates
Table 63. Hetero Basic Information, Manufacturing Base and Competitors
Table 64. Hetero Major Business
Table 65. Hetero Montelukast Drug Product and Services
Table 66. Hetero Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Hetero Recent Developments/Updates
Table 68. Unimark Basic Information, Manufacturing Base and Competitors
Table 69. Unimark Major Business
Table 70. Unimark Montelukast Drug Product and Services
Table 71. Unimark Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Unimark Recent Developments/Updates
Table 73. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Ajanta Pharma Major Business
Table 75. Ajanta Pharma Montelukast Drug Product and Services
Table 76. Ajanta Pharma Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Ajanta Pharma Recent Developments/Updates
Table 78. MACLEODS Basic Information, Manufacturing Base and Competitors
Table 79. MACLEODS Major Business
Table 80. MACLEODS Montelukast Drug Product and Services
Table 81. MACLEODS Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. MACLEODS Recent Developments/Updates
Table 83. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Jubilant Pharma Major Business
Table 85. Jubilant Pharma Montelukast Drug Product and Services
Table 86. Jubilant Pharma Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Jubilant Pharma Recent Developments/Updates
Table 88. Unichem Laboratories Basic Information, Manufacturing Base and Competitors
Table 89. Unichem Laboratories Major Business
Table 90. Unichem Laboratories Montelukast Drug Product and Services
Table 91. Unichem Laboratories Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Unichem Laboratories Recent Developments/Updates
Table 93. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 94. Amneal Pharmaceuticals Major Business
Table 95. Amneal Pharmaceuticals Montelukast Drug Product and Services
Table 96. Amneal Pharmaceuticals Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Amneal Pharmaceuticals Recent Developments/Updates
Table 98. Shanghai Anbison Lab Basic Information, Manufacturing Base and Competitors
Table 99. Shanghai Anbison Lab Major Business
Table 100. Shanghai Anbison Lab Montelukast Drug Product and Services
Table 101. Shanghai Anbison Lab Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Shanghai Anbison Lab Recent Developments/Updates
Table 103. Perrigo Basic Information, Manufacturing Base and Competitors
Table 104. Perrigo Major Business
Table 105. Perrigo Montelukast Drug Product and Services
Table 106. Perrigo Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Perrigo Recent Developments/Updates
Table 108. Cipla Basic Information, Manufacturing Base and Competitors
Table 109. Cipla Major Business
Table 110. Cipla Montelukast Drug Product and Services
Table 111. Cipla Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Cipla Recent Developments/Updates
Table 113. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 114. CSPC Ouyi Pharmaceutical Major Business
Table 115. CSPC Ouyi Pharmaceutical Montelukast Drug Product and Services
Table 116. CSPC Ouyi Pharmaceutical Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 117. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 118. Global Montelukast Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 119. Global Montelukast Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 120. Global Montelukast Drug Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 121. Market Position of Manufacturers in Montelukast Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 122. Head Office and Montelukast Drug Production Site of Key Manufacturer
Table 123. Montelukast Drug Market: Company Product Type Footprint
Table 124. Montelukast Drug Market: Company Product Application Footprint
Table 125. Montelukast Drug New Market Entrants and Barriers to Market Entry
Table 126. Montelukast Drug Mergers, Acquisition, Agreements, and Collaborations
Table 127. Global Montelukast Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 128. Global Montelukast Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 129. Global Montelukast Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 130. Global Montelukast Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 131. Global Montelukast Drug Average Price by Region (2019-2024) & (USD/Unit)
Table 132. Global Montelukast Drug Average Price by Region (2025-2030) & (USD/Unit)
Table 133. Global Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 134. Global Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 135. Global Montelukast Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Global Montelukast Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Global Montelukast Drug Average Price by Type (2019-2024) & (USD/Unit)
Table 138. Global Montelukast Drug Average Price by Type (2025-2030) & (USD/Unit)
Table 139. Global Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 140. Global Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 141. Global Montelukast Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 142. Global Montelukast Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 143. Global Montelukast Drug Average Price by Application (2019-2024) & (USD/Unit)
Table 144. Global Montelukast Drug Average Price by Application (2025-2030) & (USD/Unit)
Table 145. North America Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 146. North America Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 147. North America Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 148. North America Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 149. North America Montelukast Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 150. North America Montelukast Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 151. North America Montelukast Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 152. North America Montelukast Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Europe Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 154. Europe Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 155. Europe Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 156. Europe Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 157. Europe Montelukast Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 158. Europe Montelukast Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 159. Europe Montelukast Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 160. Europe Montelukast Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 161. Asia-Pacific Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 162. Asia-Pacific Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 163. Asia-Pacific Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 164. Asia-Pacific Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 165. Asia-Pacific Montelukast Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 166. Asia-Pacific Montelukast Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 167. Asia-Pacific Montelukast Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 168. Asia-Pacific Montelukast Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 169. South America Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 170. South America Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 171. South America Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 172. South America Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 173. South America Montelukast Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 174. South America Montelukast Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 175. South America Montelukast Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 176. South America Montelukast Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 177. Middle East & Africa Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 178. Middle East & Africa Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 179. Middle East & Africa Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 180. Middle East & Africa Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 181. Middle East & Africa Montelukast Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 182. Middle East & Africa Montelukast Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 183. Middle East & Africa Montelukast Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 184. Middle East & Africa Montelukast Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 185. Montelukast Drug Raw Material
Table 186. Key Manufacturers of Montelukast Drug Raw Materials
Table 187. Montelukast Drug Typical Distributors
Table 188. Montelukast Drug Typical Customers
Table 1. Global Montelukast Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Montelukast Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Montelukast Drug Product and Services
Table 6. Merck & Co. Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck & Co. Recent Developments/Updates
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Major Business
Table 10. Teva Montelukast Drug Product and Services
Table 11. Teva Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Teva Recent Developments/Updates
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Major Business
Table 15. Mylan Montelukast Drug Product and Services
Table 16. Mylan Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Mylan Recent Developments/Updates
Table 18. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Glenmark Pharmaceuticals Major Business
Table 20. Glenmark Pharmaceuticals Montelukast Drug Product and Services
Table 21. Glenmark Pharmaceuticals Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Glenmark Pharmaceuticals Recent Developments/Updates
Table 23. Hikma Group Basic Information, Manufacturing Base and Competitors
Table 24. Hikma Group Major Business
Table 25. Hikma Group Montelukast Drug Product and Services
Table 26. Hikma Group Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Hikma Group Recent Developments/Updates
Table 28. Sandoz Basic Information, Manufacturing Base and Competitors
Table 29. Sandoz Major Business
Table 30. Sandoz Montelukast Drug Product and Services
Table 31. Sandoz Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sandoz Recent Developments/Updates
Table 33. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Torrent Pharmaceuticals Major Business
Table 35. Torrent Pharmaceuticals Montelukast Drug Product and Services
Table 36. Torrent Pharmaceuticals Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Torrent Pharmaceuticals Recent Developments/Updates
Table 38. Lannett Company Basic Information, Manufacturing Base and Competitors
Table 39. Lannett Company Major Business
Table 40. Lannett Company Montelukast Drug Product and Services
Table 41. Lannett Company Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Lannett Company Recent Developments/Updates
Table 43. Apotex Basic Information, Manufacturing Base and Competitors
Table 44. Apotex Major Business
Table 45. Apotex Montelukast Drug Product and Services
Table 46. Apotex Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Apotex Recent Developments/Updates
Table 48. Dr. Reddys Laboratories Basic Information, Manufacturing Base and Competitors
Table 49. Dr. Reddys Laboratories Major Business
Table 50. Dr. Reddys Laboratories Montelukast Drug Product and Services
Table 51. Dr. Reddys Laboratories Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Dr. Reddys Laboratories Recent Developments/Updates
Table 53. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Aurobindo Pharma Major Business
Table 55. Aurobindo Pharma Montelukast Drug Product and Services
Table 56. Aurobindo Pharma Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Aurobindo Pharma Recent Developments/Updates
Table 58. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 59. Accord Healthcare Major Business
Table 60. Accord Healthcare Montelukast Drug Product and Services
Table 61. Accord Healthcare Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Accord Healthcare Recent Developments/Updates
Table 63. Hetero Basic Information, Manufacturing Base and Competitors
Table 64. Hetero Major Business
Table 65. Hetero Montelukast Drug Product and Services
Table 66. Hetero Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Hetero Recent Developments/Updates
Table 68. Unimark Basic Information, Manufacturing Base and Competitors
Table 69. Unimark Major Business
Table 70. Unimark Montelukast Drug Product and Services
Table 71. Unimark Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Unimark Recent Developments/Updates
Table 73. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Ajanta Pharma Major Business
Table 75. Ajanta Pharma Montelukast Drug Product and Services
Table 76. Ajanta Pharma Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Ajanta Pharma Recent Developments/Updates
Table 78. MACLEODS Basic Information, Manufacturing Base and Competitors
Table 79. MACLEODS Major Business
Table 80. MACLEODS Montelukast Drug Product and Services
Table 81. MACLEODS Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. MACLEODS Recent Developments/Updates
Table 83. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Jubilant Pharma Major Business
Table 85. Jubilant Pharma Montelukast Drug Product and Services
Table 86. Jubilant Pharma Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Jubilant Pharma Recent Developments/Updates
Table 88. Unichem Laboratories Basic Information, Manufacturing Base and Competitors
Table 89. Unichem Laboratories Major Business
Table 90. Unichem Laboratories Montelukast Drug Product and Services
Table 91. Unichem Laboratories Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Unichem Laboratories Recent Developments/Updates
Table 93. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 94. Amneal Pharmaceuticals Major Business
Table 95. Amneal Pharmaceuticals Montelukast Drug Product and Services
Table 96. Amneal Pharmaceuticals Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Amneal Pharmaceuticals Recent Developments/Updates
Table 98. Shanghai Anbison Lab Basic Information, Manufacturing Base and Competitors
Table 99. Shanghai Anbison Lab Major Business
Table 100. Shanghai Anbison Lab Montelukast Drug Product and Services
Table 101. Shanghai Anbison Lab Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Shanghai Anbison Lab Recent Developments/Updates
Table 103. Perrigo Basic Information, Manufacturing Base and Competitors
Table 104. Perrigo Major Business
Table 105. Perrigo Montelukast Drug Product and Services
Table 106. Perrigo Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Perrigo Recent Developments/Updates
Table 108. Cipla Basic Information, Manufacturing Base and Competitors
Table 109. Cipla Major Business
Table 110. Cipla Montelukast Drug Product and Services
Table 111. Cipla Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Cipla Recent Developments/Updates
Table 113. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 114. CSPC Ouyi Pharmaceutical Major Business
Table 115. CSPC Ouyi Pharmaceutical Montelukast Drug Product and Services
Table 116. CSPC Ouyi Pharmaceutical Montelukast Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 117. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 118. Global Montelukast Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 119. Global Montelukast Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 120. Global Montelukast Drug Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 121. Market Position of Manufacturers in Montelukast Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 122. Head Office and Montelukast Drug Production Site of Key Manufacturer
Table 123. Montelukast Drug Market: Company Product Type Footprint
Table 124. Montelukast Drug Market: Company Product Application Footprint
Table 125. Montelukast Drug New Market Entrants and Barriers to Market Entry
Table 126. Montelukast Drug Mergers, Acquisition, Agreements, and Collaborations
Table 127. Global Montelukast Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 128. Global Montelukast Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 129. Global Montelukast Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 130. Global Montelukast Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 131. Global Montelukast Drug Average Price by Region (2019-2024) & (USD/Unit)
Table 132. Global Montelukast Drug Average Price by Region (2025-2030) & (USD/Unit)
Table 133. Global Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 134. Global Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 135. Global Montelukast Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Global Montelukast Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Global Montelukast Drug Average Price by Type (2019-2024) & (USD/Unit)
Table 138. Global Montelukast Drug Average Price by Type (2025-2030) & (USD/Unit)
Table 139. Global Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 140. Global Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 141. Global Montelukast Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 142. Global Montelukast Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 143. Global Montelukast Drug Average Price by Application (2019-2024) & (USD/Unit)
Table 144. Global Montelukast Drug Average Price by Application (2025-2030) & (USD/Unit)
Table 145. North America Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 146. North America Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 147. North America Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 148. North America Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 149. North America Montelukast Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 150. North America Montelukast Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 151. North America Montelukast Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 152. North America Montelukast Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Europe Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 154. Europe Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 155. Europe Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 156. Europe Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 157. Europe Montelukast Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 158. Europe Montelukast Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 159. Europe Montelukast Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 160. Europe Montelukast Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 161. Asia-Pacific Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 162. Asia-Pacific Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 163. Asia-Pacific Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 164. Asia-Pacific Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 165. Asia-Pacific Montelukast Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 166. Asia-Pacific Montelukast Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 167. Asia-Pacific Montelukast Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 168. Asia-Pacific Montelukast Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 169. South America Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 170. South America Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 171. South America Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 172. South America Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 173. South America Montelukast Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 174. South America Montelukast Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 175. South America Montelukast Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 176. South America Montelukast Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 177. Middle East & Africa Montelukast Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 178. Middle East & Africa Montelukast Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 179. Middle East & Africa Montelukast Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 180. Middle East & Africa Montelukast Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 181. Middle East & Africa Montelukast Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 182. Middle East & Africa Montelukast Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 183. Middle East & Africa Montelukast Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 184. Middle East & Africa Montelukast Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 185. Montelukast Drug Raw Material
Table 186. Key Manufacturers of Montelukast Drug Raw Materials
Table 187. Montelukast Drug Typical Distributors
Table 188. Montelukast Drug Typical Customers
LIST OF FIGURES
Figure 1. Montelukast Drug Picture
Figure 2. Global Montelukast Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Montelukast Drug Consumption Value Market Share by Type in 2023
Figure 4. Tablets Examples
Figure 5. Oral Granules Examples
Figure 6. Global Montelukast Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Montelukast Drug Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Drug Store Examples
Figure 10. Others Examples
Figure 11. Global Montelukast Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Montelukast Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Montelukast Drug Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Montelukast Drug Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Montelukast Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Montelukast Drug Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Montelukast Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Montelukast Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Montelukast Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Montelukast Drug Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Montelukast Drug Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Montelukast Drug Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Montelukast Drug Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Montelukast Drug Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Montelukast Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Montelukast Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Montelukast Drug Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Montelukast Drug Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Montelukast Drug Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Montelukast Drug Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Montelukast Drug Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Montelukast Drug Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Montelukast Drug Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Montelukast Drug Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Montelukast Drug Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Montelukast Drug Consumption Value Market Share by Region (2019-2030)
Figure 53. China Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Montelukast Drug Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Montelukast Drug Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Montelukast Drug Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Montelukast Drug Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Montelukast Drug Market Drivers
Figure 74. Montelukast Drug Market Restraints
Figure 75. Montelukast Drug Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Montelukast Drug in 2023
Figure 78. Manufacturing Process Analysis of Montelukast Drug
Figure 79. Montelukast Drug Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Montelukast Drug Picture
Figure 2. Global Montelukast Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Montelukast Drug Consumption Value Market Share by Type in 2023
Figure 4. Tablets Examples
Figure 5. Oral Granules Examples
Figure 6. Global Montelukast Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Montelukast Drug Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Drug Store Examples
Figure 10. Others Examples
Figure 11. Global Montelukast Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Montelukast Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Montelukast Drug Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Montelukast Drug Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Montelukast Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Montelukast Drug Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Montelukast Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Montelukast Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Montelukast Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Montelukast Drug Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Montelukast Drug Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Montelukast Drug Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Montelukast Drug Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Montelukast Drug Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Montelukast Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Montelukast Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Montelukast Drug Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Montelukast Drug Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Montelukast Drug Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Montelukast Drug Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Montelukast Drug Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Montelukast Drug Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Montelukast Drug Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Montelukast Drug Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Montelukast Drug Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Montelukast Drug Consumption Value Market Share by Region (2019-2030)
Figure 53. China Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Montelukast Drug Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Montelukast Drug Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Montelukast Drug Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Montelukast Drug Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Montelukast Drug Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Montelukast Drug Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Montelukast Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Montelukast Drug Market Drivers
Figure 74. Montelukast Drug Market Restraints
Figure 75. Montelukast Drug Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Montelukast Drug in 2023
Figure 78. Manufacturing Process Analysis of Montelukast Drug
Figure 79. Montelukast Drug Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
